<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000277243"><TermName>lonafarnib</TermName><TermPronunciation>(loh-nah-FAR-nib)</TermPronunciation><TermDefinition><DefinitionText>An anticancer drug that belongs to the family of drugs called enzyme inhibitors. Also called SCH 66336.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731225" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;lonafarnib&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731224" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;lonafarnib&quot;" language="es" id="_4"/><SpanishTermName>lonafarnib</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento contra el cáncer que es un tipo de inhibidor enzimático. También se llama SCH 66336.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-02-21</DateFirstPublished><DateLastModified>2003-02-07</DateLastModified></GlossaryTerm>
